Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Martin Schrappe

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mejstríková Ester; Fronková Eva; Kalina Tomás; Omelka Marek; Batinic Drago; Dubravcic Klara; Pospísilová Klára; Vásková Martina; Luria Drorit; Cheng Suk Hang; Ng Margaret; Leung Yonna; Kappelmayer Janos; Kiss Flora; Izraeli Shai; Stark Batia; Schrappe Martin; Trka Jan; Starý Jan; Hrusák Ondrej
Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.
Sallan Stephen E; Schrappe Martin; Silverman Lewis B
Treating childhood leukemia without cranial irradiation.
Schwarz Arne Kristian; Stanulla Martin; Cario Gunnar; Flohr Thomas; Sutton Rosemary; Möricke Anja; Anker Philippe; Stroun Maurice; Welte Karl; Bartram Claus R; Schrappe Martin; Schrauder André
Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Martin Schrappe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Mejstríková Ester; Fronková Eva; Kalina Tomás; Omelka Marek; Batinic Drago; Dubravcic Klara; Pospísilová Klára; Vásková Martina; Luria Drorit; Cheng Suk Hang; Ng Margaret; Leung Yonna; Kappelmayer Janos; Kiss Flora; Izraeli Shai; Stark Batia; Schrappe Martin; Trka Jan; Starý Jan; Hrusák Ondrej
Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry.
Pediatric blood & cancer 2010;54(1):62-70.
2009: Sallan Stephen E; Schrappe Martin; Silverman Lewis B
Treating childhood leukemia without cranial irradiation.
The New England journal of medicine 2009;361(13):1310; author reply 1311-2.
2009: Schwarz Arne Kristian; Stanulla Martin; Cario Gunnar; Flohr Thomas; Sutton Rosemary; Möricke Anja; Anker Philippe; Stroun Maurice; Welte Karl; Bartram Claus R; Schrappe Martin; Schrauder André
Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
Annals of hematology 2009;88(9):897-905.
2009: Stanulla Martin; Schaeffeler Elke; Möricke Anja; Coulthard Sally A; Cario Gunnar; Schrauder André; Kaatsch Peter; Dördelmann Michael; Welte Karl; Zimmermann Martin; Reiter Alfred; Eichelbaum Michel; Riehm Hansjörg; Schrappe Martin; Schwab Matthias
Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
Blood 2009;114(7):1314-8.
2009: Reichardt C; Eberlein-Gonska M; Schrappe M; Gastmeier P
[Clean Hands Campaign. No chance for hospital infections!]
Der Unfallchirurg 2009;112(7):679-82.
2009: Remke Marc; Pfister Stefan; Kox Corinne; Toedt Grischa; Becker Natalia; Benner Axel; Werft Wiebke; Breit Stephen; Liu Shuangyou; Engel Felix; Wittmann Andrea; Zimmermann Martin; Stanulla Martin; Schrappe Martin; Ludwig Wolf-Dieter; Bartram Claus R; Radlwimmer Bernhard; Muckenthaler Martina U; Lichter Peter; Kulozik Andreas E
High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response.
Blood 2009;114(5):1053-62.
2009: Dai Liping; Gast Andreas; Horska Alexandra; Schrappe Martin; Bartram Claus R; Hemminki Kari; Kumar Rajiv; Bermejo Justo Lorenzo
A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes.
Pediatric blood & cancer 2009;52(7):819-23.
2009: Kawamata Norihiko; Ogawa Seishi; Seeger Karl; Kirschner-Schwabe Renate; Huynh Thien; Chen John; Megrabian Nairi; Harbott Jochen; Zimmermann Martin; Henze Günter; Schrappe Martin; Bartram Claus R; Koeffler H Phillip
Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia.
International journal of oncology 2009;34(6):1603-12.
2009: Kidas Ekaterini; Möricke Anja; Beier Rita; Welte Karl; Schrappe Martin; Stanulla Martin; Grigull Lorenz
Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study.
International journal of hematology 2009;89(5):584-91.
2009: Van der Velden V H J; Corral L; Valsecchi M G; Jansen M W J C; De Lorenzo P; Cazzaniga G; Panzer-Grümayer E R; Schrappe M; Schrauder A; Meyer C; Marschalek R; Nigro L L; Metzler M; Basso G; Mann G; Den Boer M L; Biondi A; Pieters R; Van Dongen J J M;
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(6):1073-9.
2009: Lönnerholm Gudmar; Valsecchi Maria Grazia; De Lorenzo Paola; Schrappe Martin; Hovi Liisa; Campbell Myriam; Mann Georg; Janka-Schaub Gritta; Li Chi-Kong; Stary Jan; Hann Ian; Pieters Rob;
Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia.
Pediatric blood & cancer 2009;52(5):596-601.
2009: Lauten Melchior; Fernandez-Munoz Ivonne; Gerdes Katrin; von Neuhoff Nils; Welte Karl; Schlegelberger Brigitte; Schrappe Martin; Beger Carmela
Kinetics of the in vivo expression of glucocorticoid receptor splice variants during prednisone treatment in childhood acute lymphoblastic leukaemia.
Pediatric blood & cancer 2009;52(4):459-63.
2009: Ratei R; Basso G; Dworzak M; Gaipa G; Veltroni M; Rhein P; Biondi A; Schrappe M; Ludwig W-D; Karawajew L;
Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(3):528-34.
2008: Teuffel Oliver; Stanulla Martin; Cario Gunnar; Ludwig Wolf D; Rottgers Silja; Schafer Beat W; Zimmermann Martin; Schrappe Martin; Niggli Felix K
Anemia and survival in childhood acute lymphoblastic leukemia.
Haematologica 2008;93(11):1652-7.
2008: Bercovich Dani; Ganmore Ithamar; Scott Linda M; Wainreb Gilad; Birger Yehudit; Elimelech Arava; Shochat Chen; Cazzaniga Giovanni; Biondi Andrea; Basso Giuseppe; Cario Gunnar; Schrappe Martin; Stanulla Martin; Strehl Sabine; Haas Oskar A; Mann Georg; Binder Vera; Borkhardt Arndt; Kempski Helena; Trka Jan; Bielorei Bella; Avigad Smadar; Stark Batia; Smith Owen; Dastugue Nicole; Bourquin Jean-Pierre; Tal Nir Ben; Green Anthony R; Izraeli Shai
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
Lancet 2008;372(9648):1484-92.
2008: Cario Gunnar; Fetz Andrea; Bretscher Christian; Möricke Anja; Schrauder Andre; Stanulla Martin; Schrappe Martin
Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia.
Annals of hematology 2008;87(9):709-16.
2008: Kawamata Norihiko; Ogawa Seishi; Zimmermann Martin; Niebuhr Birte; Stocking Carol; Sanada Masashi; Hemminki Kari; Yamatomo Go; Nannya Yasuhito; Koehler Rolf; Flohr Thomas; Miller Carl W; Harbott Jochen; Ludwig Wolf-Dieter; Stanulla Martin; Schrappe Martin; Bartram Claus R; Koeffler H Phillip
Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(33):11921-6.
2008: le Viseur Christoph; Hotfilder Marc; Bomken Simon; Wilson Kerrie; Röttgers Silja; Schrauder André; Rosemann Annegret; Irving Julie; Stam Ronald W; Shultz Leonard D; Harbott Jochen; Jürgens Heribert; Schrappe Martin; Pieters Rob; Vormoor Josef
In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties.
Cancer cell 2008;14(1):47-58.
2008: Attarbaschi Andishe; Mann Georg; Panzer-Grümayer Renate; Röttgers Silja; Steiner Manuel; König Margit; Csinady Eva; Dworzak Michael N; Seidel Markus; Janousek Dasa; Möricke Anja; Reichelt Carsten; Harbott Jochen; Schrappe Martin; Gadner Helmut; Haas Oskar A
Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3046-50.
2008: Schrauder A; von Stackelberg A; Schrappe M; Cornish J; Peters Christina;
Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials.
Bone marrow transplantation 2008;41 Suppl 2():S71-4.
2008: Balduzzi Adriana; De Lorenzo Paola; Schrauder André; Conter Valentino; Uderzo Cornelio; Peters Christina; Klingebiel Thomas; Stary Jan; Felice Maria S; Magyarosy Edina; Schrappe Martin; Dini Giorgio; Gadner Helmut; Valsecchi Maria Grazia
Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time.
Haematologica 2008;93(6):925-9.
2008: Steinemann Doris; Cario Gunnar; Stanulla Martin; Karawajew Leonid; Tauscher Marcel; Weigmann Anja; Göhring Gudrun; Ludwig Wolf-Dieter; Harbott Jochen; Radlwimmer Bernhard; Bartram Claus; Lichter Peter; Schrappe Martin; Schlegelberger Brigitte
Copy number alterations in childhood acute lymphoblastic leukemia and their association with minimal residual disease.
Genes, chromosomes & cancer 2008;47(6):471-80.
2008: Fronkova E; Mejstrikova E; Avigad S; Chik K W; Castillo L; Manor S; Reznickova L; Valova T; Zdrahalova K; Hrusak O; Jabali Y; Schrappe M; Conter V; Izraeli S; Li C K; Stark B; Stary J; Trka J
Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(5):989-97.
2008: Möricke Anja; Reiter Alfred; Zimmermann Martin; Gadner Helmut; Stanulla Martin; Dördelmann Michael; Löning Lutz; Beier Rita; Ludwig Wolf-Dieter; Ratei Richard; Harbott Jochen; Boos Joachim; Mann Georg; Niggli Felix; Feldges Andreas; Henze Günter; Welte Karl; Beck Jörn-Dirk; Klingebiel Thomas; Niemeyer Charlotte; Zintl Felix; Bode Udo; Urban Christian; Wehinger Helmut; Niethammer Dietrich; Riehm Hansjörg; Schrappe Martin;
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
Blood 2008;111(9):4477-89.
2008: Flohr T; Schrauder A; Cazzaniga G; Panzer-Grümayer R; van der Velden V; Fischer S; Stanulla M; Basso G; Niggli F K; Schäfer B W; Sutton R; Koehler R; Zimmermann M; Valsecchi M G; Gadner H; Masera G; Schrappe M; van Dongen J J M; Biondi A; Bartram C R;
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2008;22(4):771-82.
2008: Burkhardt Birgit; Moericke Anja; Klapper Wolfram; Greene Franziska; Salzburg Janina; Damm-Welk Christine; Zimmermann Martin; Strauch Konstantin; Ludwig Wolf-Dieter; Schrappe Martin; Reiter Alfred
Pediatric precursor T lymphoblastic leukemia and lymphoblastic lymphoma: Differences in the common regions with loss of heterozygosity at chromosome 6q and their prognostic impact.
Leukemia & lymphoma 2008;49(3):451-61.
2008: Kawamata Norihiko; Ogawa Seishi; Zimmermann Martin; Kato Motohiro; Sanada Masashi; Hemminki Kari; Yamatomo Go; Nannya Yasuhito; Koehler Rolf; Flohr Thomas; Miller Carl W; Harbott Jochen; Ludwig Wolf-Dieter; Stanulla Martin; Schrappe Martin; Bartram Claus R; Koeffler H Phillip
Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray.
Blood 2008;111(2):776-84.
2008: Schrappe Martin
Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia.
Radiation protection dosimetry 2008;132(2):130-3.
2007: Stanulla Martin; Dynybil Christian; Bartels Dorothee B; Dördelmann Michael; Löning Lutz; Claviez Alexander; Schrappe Martin;
The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
Haematologica 2007;92(11):1581-2.
2007: Kager Leo; Lion Thomas; Attarbaschi Andishe; Koenig Margit; Strehl Sabine; Haas Oskar A; Dworzak Michael N; Schrappe Martin; Gadner Helmut; Mann Georg;
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children.
Haematologica 2007;92(11):1561-4.
2007: Mann Georg; Attarbaschi Andishe; Burkhardt Birgit; Niggli Felix; Klapper Wolfram; Ludwig Wolf-Dieter; Schrappe Martin; Zimmermann Martin; Gadner Helmut; Reiter Alfred;
Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
British journal of haematology 2007;139(3):443-9.
2007: Cario Gunnar; Izraeli Shai; Teichert Anja; Rhein Peter; Skokowa Julia; Möricke Anja; Zimmermann Martin; Schrauder Andre; Karawajew Leonid; Ludwig Wolf-Dieter; Welte Karl; Schünemann Holger J; Schlegelberger Brigitte; Schrappe Martin; Stanulla Martin
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4813-20.
2007: Salzburg Janina; Burkhardt Birgit; Zimmermann Martin; Wachowski Olga; Woessmann Wilhelm; Oschlies Ilske; Klapper Wolfram; Wacker Hans-Heinrich; Ludwig Wolf-Dieter; Niggli Felix; Mann Georg; Gadner Helmut; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred
Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3915-22.
2007: Bornhauser Beat C; Bonapace Laura; Lindholm Dan; Martinez Rodrigo; Cario Gunnar; Schrappe Martin; Niggli Felix K; Schäfer Beat W; Bourquin Jean-Pierre
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Blood 2007;110(6):2084-91.
2007: Stanulla Martin; Cario Gunnar; Meissner Barbara; Schrauder André; Möricke Anja; Riehm Hansjörg; Schrappe Martin
Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
Blood cells, molecules & diseases 2007;39(2):160-3.
2007: Nachman James B; Heerema Nyla A; Sather Harland; Camitta Bruce; Forestier Erik; Harrison Christine J; Dastugue Nicole; Schrappe Martin; Pui Ching-Hon; Basso Giuseppe; Silverman Lewis B; Janka-Schaub Gritta E
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.
Blood 2007;110(4):1112-5.
2007: Pieters Rob; Schrappe Martin; De Lorenzo Paola; Hann Ian; De Rossi Giulio; Felice Maria; Hovi Liisa; LeBlanc Thierry; Szczepanski Tomasz; Ferster Alice; Janka Gritta; Rubnitz Jeffrey; Silverman Lewis; Stary Jan; Campbell Myriam; Li Chi-Kong; Mann Georg; Suppiah Ram; Biondi Andrea; Vora Ajay; Valsecchi Maria Grazia
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.
Lancet 2007;370(9583):240-50.
2007: Rhein P; Scheid S; Ratei R; Hagemeier C; Seeger K; Kirschner-Schwabe R; Moericke A; Schrappe M; Spang R; Ludwig W-D; Karawajew L
Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(5):897-905.
2007: Schrauder André; Henke-Gendo Cornelia; Seidemann Kathrin; Sasse Michael; Cario Gunnar; Moericke Anja; Schrappe Martin; Heim Albert; Wessel Armin
Varicella vaccination in a child with acute lymphoblastic leukaemia.
Lancet 2007;369(9568):1232.
2007: van der Velden V H J; Panzer-Grümayer E R; Cazzaniga G; Flohr T; Sutton R; Schrauder A; Basso G; Schrappe M; Wijkhuijs J M; Konrad M; Bartram C R; Masera G; Biondi A; van Dongen J J M
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(4):706-13.
2007: Jansen M W J C; Corral L; van der Velden V H J; Panzer-Grümayer R; Schrappe M; Schrauder A; Marschalek R; Meyer C; den Boer M L; Hop W J C; Valsecchi M G; Basso G; Biondi A; Pieters R; van Dongen J J M
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(4):633-41.
2007: Krappmann Paul; Paulides Marios; Stöhr Wolfgang; Ittner Edith; Plattig Bernhard; Nickel Petra; Lackner Herwig; Schrappe Martin; Janka Gritta; Beck Jörn D; Langer Thorsten
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.
Pediatric hematology and oncology 2007;24(2):101-9.
2007: Conter Valentino; Valsecchi Maria Grazia; Silvestri Daniela; Campbell Myriam; Dibar Eduardo; Magyarosy Edina; Gadner Helmut; Stary Jan; Benoit Yves; Zimmermann Martin; Reiter Alfred; Riehm Hansjörg; Masera Giuseppe; Schrappe Martin
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial.
Lancet 2007;369(9556):123-31.
2006: Schrauder André; Reiter Alfred; Gadner Helmut; Niethammer Dietrich; Klingebiel Thomas; Kremens Bernhard; Peters Christina; Ebell Wolfram; Zimmermann Martin; Niggli Felix; Ludwig Wolf-Dieter; Riehm Hansjörg; Welte Karl; Schrappe Martin
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5742-9.
2006: Staal F J T; Cario G; Cazzaniga G; Haferlach T; Heuser M; Hofmann W-K; Mills K; Schrappe M; Stanulla M; Wingen L U; van Dongen J J M; Schlegelberger B
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(8):1385-92.
2006: Breit Stephen; Stanulla Martin; Flohr Thomas; Schrappe Martin; Ludwig Wolf-Dieter; Tolle Gabriele; Happich Margit; Muckenthaler Martina U; Kulozik Andreas E
Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.
Blood 2006;108(4):1151-7.
2006: Meyer Lüder Hinrich; Karawajew Leonid; Schrappe Martin; Ludwig Wolf-Dieter; Debatin Klaus-Michael; Stahnke Karsten
Cytochrome c-related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL.
Blood 2006;107(11):4524-31.
2006: Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
British journal of haematology 2006;133(3):337-44.
2006: Metzler Markus; Mann Georg; Monschein Uli; Lodzinski Martin; Gall Christine; Flohr Thomas; Viehmann Susanne; Langer Thorsten; Schrappe Martin; Gadner Helmut; Haas Oskar A; Panzer-Grümayer E Renate
Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene.
Haematologica 2006;91(5):683-6.
2006: Lauten M; Schrauder A; Kardinal C; Harbott J; Welte K; Schlegelberger B; Schrappe M; von Neuhoff N
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistance.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(5):820-6.
2006: Maecker B; Mougiakakos D; Zimmermann M; Behrens M; Hollander S; Schrauder A; Schrappe M; Welte K; Klein C
Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(4):645-9.
2006: Claviez Alexander; Eckert Cornelia; Seeger Karl; Schrauder André; Schrappe Martin; Henze Günter; von Stackelberg Arend
Rituximab plus chemotherapy in children with relapsed or refractory CD20-positive B-cell precursor acute lymphoblastic leukemia.
Haematologica 2006;91(2):272-3.
2006: Burkhardt Birgit; Woessmann Wilhelm; Zimmermann Martin; Kontny Udo; Vormoor Josef; Doerffel Wolfgang; Mann Georg; Henze Guenter; Niggli Felix; Ludwig Wolf-Dieter; Janssen Dirk; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):491-9.
2006: Gadner H; Masera G; Schrappe M; Eden T; Benoit Y; Harrison C; Nachman J; Pui C H
The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):9-17.
2005: Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig W-D; Riehm H; Schrappe M
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Klinische Pädiatrie 2005;217(6):310-20.
2005: Einsiedel Hagen Graf; von Stackelberg Arend; Hartmann Reinhard; Fengler Rüdiger; Schrappe Martin; Janka-Schaub Gritta; Mann Georg; Hählen Karel; Göbel Ulrich; Klingebiel Thomas; Ludwig Wolf-Dieter; Henze Günter
Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7942-50.
2005: Burkhardt Birgit; Zimmermann Martin; Oschlies Ilske; Niggli Felix; Mann Georg; Parwaresch Reza; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred;
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
British journal of haematology 2005;131(1):39-49.
2005: Berthold Frank; Boos Joachim; Burdach Stefan; Erttmann Rudolf; Henze Günter; Hermann Johann; Klingebiel Thomas; Kremens Bernhard; Schilling Freimut H; Schrappe Martin; Simon Thorsten; Hero Barbara
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.
The lancet oncology 2005;6(9):649-58.
2005: Balduzzi Adriana; Valsecchi Maria Grazia; Uderzo Cornelio; De Lorenzo Paola; Klingebiel Thomas; Peters Christina; Stary Jan; Felice Maria S; Magyarosy Edina; Conter Valentino; Reiter Alfred; Messina Chiara; Gadner Helmut; Schrappe Martin
Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
Lancet 2005;366(9486):635-42.
2005: Teuffel O; Schrauder A; Sykora K W; Zimmermann M; Reiter A; Welte K; Schrappe M
The impact of cyclosporin A on acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents with acute lymphoblastic leukemia.
Bone marrow transplantation 2005;36(2):145-50.
2005: Aricó M; Baruchel A; Bertrand Y; Biondi A; Conter V; Eden T; Gadner H; Gaynon P; Horibe K; Hunger S P; Janka-Schaub G; Masera G; Nachman J; Pieters R; Schrappe M; Schmiegelow K; Valsecchi M G; Pui C-H
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1145-52.
2005: Schnakenberg Eckart; Mehles Andrea; Cario Gunnar; Rehe Klaus; Seidemann Kathrin; Schlegelberger Brigitte; Elsner Holger A; Welte Karl H; Schrappe Martin; Stanulla Martin
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population.
BMC medical genetics 2005;6():23.
2005: Simon T; Hero B; Faldum A; Handgretinger R; Schrappe M; Niethammer D; Berthold F
Infants with stage 4 neuroblastoma: the impact of the chimeric anti-GD2-antibody ch14.18 consolidation therapy.
Klinische Pädiatrie 2005;217(3):147-52.
2005: Cario Gunnar; Skokowa Julia; Wang Zheng; Bucan Vesna; Zeidler Cornelia; Stanulla Martin; Schrappe Martin; Welte Karl
Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor.
British journal of haematology 2005;129(2):275-8.
2005: Moorman A V; Raimondi S C; Pui C H; Baruchel A; Biondi A; Carroll A J; Forestier E; Gaynon P S; Harbott J; Harms D O; Heerema N; Pieters R; Schrappe M; Silverman L B; Vilmer E; Harrison C J;
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(4):557-63.
2005: Stanulla Martin; Schaeffeler Elke; Flohr Thomas; Cario Gunnar; Schrauder André; Zimmermann Martin; Welte Karl; Ludwig Wolf-Dieter; Bartram Claus R; Zanger Ulrich M; Eichelbaum Michel; Schrappe Martin; Schwab Matthias
Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
JAMA : the journal of the American Medical Association 2005;293(12):1485-9.
2005: Bürger Britta; Beier Rita; Zimmermann Martin; Beck Jörn D; Reiter Alfred; Schrappe Martin
Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
Pediatric blood & cancer 2005;44(3):220-5.
2005: Hotfilder Marc; Röttgers Silja; Rosemann Annegret; Schrauder André; Schrappe Martin; Pieters Rob; Jürgens Heribert; Harbott Jochen; Vormoor Josef
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Cancer research 2005;65(4):1442-9.
2005: Grigull L; Beilken A; Schrappe M; Das A; Luecke T; Sander A; Stanulla M; Rehe K; Sauer M; Schmid H; Welte K; Lukacs Z; Gal A; Sykora K W
Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).
Bone marrow transplantation 2005;35(3):265-9.
2005: Woessmann Wilhelm; Seidemann Kathrin; Mann Georg; Zimmermann Martin; Burkhardt Birgit; Oschlies Ilske; Ludwig Wolf-Dieter; Klingebiel Thomas; Graf Norbert; Gruhn Bernd; Juergens Heribert; Niggli Felix; Parwaresch Reza; Gadner Helmut; Riehm Hansjoerg; Schrappe Martin; Reiter Alfred;
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.
Blood 2005;105(3):948-58.
2005: Stanulla Martin; Schäffeler Elke; Arens Stefan; Rathmann Anke; Schrauder André; Welte Karl; Eichelbaum Michel; Zanger Ulrich M; Schrappe Martin; Schwab Matthias
GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia.
International journal of hematology 2005;81(1):39-44.
2005: Stanulla Martin; Seidemann Kathrin; Schnakenberg Eckart; Book Marion; Mehles Andrea; Welte Karl; Schrappe Martin; Reiter Alfred
Methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and risk of pediatric non-Hodgkin lymphoma in a German study population.
Blood 2005;105(2):906-7.
2005: Cloppenborg T; Stanulla M; Zimmermann M; Schrappe M; Welte K; Klein C
Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(1):44-8.
2005: Cario Gunnar; Stanulla Martin; Fine Bernard M; Teuffel Oliver; Neuhoff Nils V; Schrauder André; Flohr Thomas; Schäfer Beat W; Bartram Claus R; Welte Karl; Schlegelberger Brigitte; Schrappe Martin
Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia.
Blood 2005;105(2):821-6.
2004: Kracht Thorben; Schrappe Martin; Strehl Sabine; Reiter Alfred; Elsner Holger-Andreas; Trka Jan; Cario Gunnar; Viehmann Susanne; Harbott Jochen; Borkhardt Arndt; Metzler Markus; Langer Thorsten; Repp Reinald; Marschalek Rolf; Welte Karl; Haas Oskar A; Stanulla Martin
NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Haematologica 2004;89(12):1492-7.
2004: Meissner B; Stanulla M; Ludwig W-D; Harbott J; Möricke A; Welte K; Schrappe M
The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(11):1920-3.
2004: Metzler Markus; Strissel Pamela L; Strick Reiner; Niemeyer Charlotte; Roettgers Silja; Borkhardt Arndt; Harbott Jochen; Ludwig Wolf D; Stanulla Martin; Schrappe Martin; Reinhardt Dirk; Creutzig Ursula; Beck Joern D; Rascher Wolfgang; Repp Reinald; Langer Thorsten
Emergence of translocation t(9;11)-positive leukemia during treatment of childhood acute lymphoblastic leukemia.
Genes, chromosomes & cancer 2004;41(3):291-6.
2004: Machatschek Jan-Nicolas; Schrauder André; Helm Frank; Schrappe Martin; Claviez Alexander
Acute lymphoblastic leukemia and Klinefelter syndrome in children: two cases and review of the literature.
Pediatric hematology and oncology 2004;21(7):621-6.
2004: Eden Tim; Pui Ching-Hon; Schrappe Martin; Tognoni Gianni; Masera Giuseppe;
All children have a right to full access to treatment for cancer.
Lancet 2004;364(9440):1121-2.
2004: Simon Thorsten; Hero Barbara; Faldum Andreas; Handgretinger Rupert; Schrappe Martin; Niethammer Dietrich; Berthold Frank
Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(17):3549-57.
2004: Masera Giuseppe; Eden Tim; Schrappe Martin; Nachman James; Gadner Helmut; Gaynon Paul; Evans William E; Pui Ching-Hon;
Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia.
Pediatric blood & cancer 2004;43(2):103-4.
2004: Teuffel Oliver; Dettling Marcel; Cario Gunnar; Stanulla Martin; Schrappe Martin; Bühlmann Peter; Niggli Felix K; Schäfer Beat W
Gene expression profiles and risk stratification in childhood acute lymphoblastic leukemia.
Haematologica 2004;89(7):801-8.
2004: Bader Peter; Kreyenberg Hermann; Hoelle Walter; Dueckers Gregor; Handgretinger Rupert; Lang Peter; Kremens Bernhard; Dilloo Dagmar; Sykora Karl-Walter; Schrappe Martin; Niemeyer Charlotte; Von Stackelberg Arend; Gruhn Bernd; Henze Günter; Greil Johann; Niethammer Dietrich; Dietz Klaus; Beck James F; Klingebiel Thomas
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1696-705.
2004: Heerema N A; Harbott J; Galimberti S; Camitta B M; Gaynon P S; Janka-Schaub G; Kamps W; Basso G; Pui C-H; Schrappe M; Auclerc M-F; Carroll A J; Conter V; Harrison C J; Pullen J; Raimondi S C; Richards S; Riehm H; Sather H N; Shuster J J; Silverman L B; Valsecchi M G; Aricò M;
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):693-702.
2004: Fine Bernard M; Stanulla Martin; Schrappe Martin; Ho Minh; Viehmann Susanne; Harbott Jochen; Boxer Linda M
Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia.
Blood 2004;103(3):1043-9.
2004: Metzler M; Brehm U; Langer T; Viehmann S; Borkhardt A; Stanulla M; Schrappe M; Harbott J; Beck J D; Rascher W; Repp R
Asymmetric multiplex-polymerase chain reaction - a high throughput method for detection and sequencing genomic fusion sites in t(4;11).
British journal of haematology 2004;124(1):47-54.
2004: Pui Ching-Hon; Schrappe Martin; Ribeiro Raul C; Niemeyer Charlotte M
Childhood and adolescent lymphoid and myeloid leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2004;():118-45.
2004: Schrappe M
Evolution of BFM trials for childhood ALL.
Annals of hematology 2004;83 Suppl 1():S121-3.
2003: Grigull L; Beier R; Schrauder A; Kirschner P; Loening L; Jack T; Welte K; Sykora K W; Schrappe M
Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL.
Mycoses 2003;46(11-12):441-6.
2003: Lauten Melchior; Cario Gunnar; Asgedom Girmay; Welte Karl; Schrappe Martin
Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
Haematologica 2003;88(11):1253-8.
2003: Schrappe Martin
Prognostic factors in childhood acute lymphoblastic leukemia.
Indian journal of pediatrics 2003;70(10):817-24.
2003: Lauten M; Beger C; Gerdes K; Asgedom G; Kardinal C; Welte K; Schrappe M
Expression of heat-shock protein 90 in glucocorticoid-sensitive and -resistant childhood acute lymphoblastic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(8):1551-6.
2003: Berthold F; Hero B; Kremens B; Handgretinger R; Henze G; Schilling F H; Schrappe M; Simon T; Spix C
Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.
Cancer letters 2003;197(1-2):11-7.
2003: Beger Carmela; Gerdes Katrin; Lauten Melchior; Tissing Wim J E; Fernandez-Munoz Ivonne; Schrappe Martin; Welte Karl
Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukaemia cells using an isoform-specific real-time polymerase chain reaction approach.
British journal of haematology 2003;122(2):245-52.
2003: Jumaa Hassan; Bossaller Lukas; Portugal Karina; Storch Bettina; Lotz Michael; Flemming Alexandra; Schrappe Martin; Postila Ville; Riikonen Pekka; Pelkonen Jukka; Niemeyer Charlotte M; Reth Michael
Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.
Nature 2003;423(6938):452-6.
2003: Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A;
Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1782-9.
2003: Langer Thorsten; Metzler Markus; Reinhardt Dirk; Viehmann Susanne; Borkhardt Arndt; Reichel Martin; Stanulla Martin; Schrappe Martin; Creutzig Ursula; Ritter Jörg; Leis Thomas; Jacobs Ulla; Harbott Jochen; Beck Jörn D; Rascher Wolfgang; Repp Reinald
Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
Genes, chromosomes & cancer 2003;36(4):393-401.
2003: Lauten Melchior; Asgedom Girmay; Welte Karl; Schrappe Martin; Stanulla Martin
Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
Haematologica 2003;88(3):353-4.
2003: Wössmann W; Schrappe M; Meyer U; Zimmermann M; Reiter A
Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase.
Annals of hematology 2003;82(3):160-5.
2003: Warmann Steven; Fuchs Jörg; Jesch Nathalie K; Schrappe Martin; Ure Benno M
A prospective study of minimally invasive techniques in pediatric surgical oncology: preliminary report.
Medical and pediatric oncology 2003;40(3):155-7.
2003: Bürger Britta; Zimmermann Martin; Mann Georg; Kühl Joachim; Löning Lutz; Riehm Hansjörg; Reiter Alfred; Schrappe Martin
Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):184-8.
2002: Schrappe Martin; Beier Rita; Bürger Britta
New treatment strategies in childhood acute lymphoblastic leukaemia.
Best practice & research. Clinical haematology 2002;15(4):729-40.
2002: Takeuchi Seisho; Takeuchi Naoko; Tsukasaki Kunihiro; Bartram Claus R; Zimmermann Martin; Schrappe Martin; Taguchi Hirokuni; Koeffler H Phillip
Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemia.
British journal of haematology 2002;119(4):985-7.
2002: Attarbaschi Andishe; Mann Georg; Dworzak Michael; Wiesbauer Peter; Schrappe Martin; Gadner Helmut
Mediastinal mass in childhood T-cell acute lymphoblastic leukemia: significance and therapy response.
Medical and pediatric oncology 2002;39(6):558-65.
2002: Borkhardt A; Wuchter C; Viehmann S; Pils S; Teigler-Schlegel A; Stanulla M; Zimmermann M; Ludwig W-D; Janka-Schaub G; Schrappe M; Harbott J
Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1685-90.
2002: Lauten M; Matthias T; Stanulla M; Beger C; Welte K; Schrappe M
Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(8):1437-42.
2002: Dieckvoss Björn-Ole; Stanulla Martin; Schrappe Martin; Beier Rita; Zimmermann Martin; Welte Karl; Reiter Alfred
Polymorphisms within glutathione S-transferase genes in pediatric non-Hodgkin's lymphoma.
Haematologica 2002;87(7):709-13; discussion 713.
2002: Pui Ching-Hon; Gaynon Paul S; Boyett James M; Chessells Judith M; Baruchel André; Kamps Willem; Silverman Lewis B; Biondi Andrea; Harms Dörthe O; Vilmer Etienne; Schrappe Martin; Camitta Bruce
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
Lancet 2002;359(9321):1909-15.
2002: Willemse Marja J; Seriu Taku; Hettinger Klaudia; d'Aniello Elisabetta; Hop Wim C J; Panzer-Grümayer E Renate; Biondi Andrea; Schrappe Martin; Kamps Willem A; Masera Guiseppe; Gadner Helmut; Riehm Hansjoerg; Bartram Claus R; van Dongen Jacques J M
Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.
Blood 2002;99(12):4386-93.
2002: Wuchter Christian; Ruppert Velia; Schrappe Martin; Dörken Bernd; Ludwig Wolf-Dieter; Karawajew Leonid
In vitro susceptibility to dexamethasone- and doxorubicin-induced apoptotic cell death in context of maturation stage, responsiveness to interleukin 7, and early cytoreduction in vivo in childhood T-cell acute lymphoblastic leukemia.
Blood 2002;99(11):4109-15.
2002: Müller Hans-Joachim; Beier Rita; da Palma João Casimiro; Lanvers Claudia; Ahlke Elvira; von Schütz Volker; Gunkel Martin; Horn Alexander; Schrappe Martin; Henze Günter; Kranz Karen; Boos Joachim
PEG-asparaginase (Oncaspar) 2500 U/m(2) BSA in reinduction and relapse treatment in the ALL/NHL-BFM protocols.
Cancer chemotherapy and pharmacology 2002;49(2):149-54.
2002: Cornely O A; Bethe U; Seifert H; Breuer K; Schütt-Gerowitt H; Salzberger B; Schrappe M; Fätkenheuer G
A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
Annals of hematology 2002;81(1):37-43.
2001: Müller H J; Beier R; Löning L; Blütters-Sawatzki R; Dörffel W; Maass E; Müller-Weihrich S; Scheel-Walter H G; Scherer F; Stahnke K; Schrappe M; Horn A; Lümkemann K; Boos J
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatment.
British journal of haematology 2001;114(4):794-9.
2001: Uderzo C; Balduzzi A; De Lorenzo P; Valsecchi M G; Gadner H; Klingebiel T; Zimmermann M; Schrappe M;
Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (VHR) childhood acute lymphoblastic leukaemia in first complete remission.
Bone marrow transplantation 2001;28 Suppl 1():S22-4.
2001: Lauten M; Stanulla M; Zimmermann M; Welte K; Riehm H; Schrappe M
Clinical outcome of patients with childhood acute lymphoblastic leukaemia and an initial leukaemic blood blast count of less than 1000 per microliter.
Klinische Pädiatrie 2001;213(4):169-74.
2001: Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 2001;97(12):3699-706.
2001: Cornely O A; Bethe U; Salzberger B; Franzen C; Hartmann P; Steinmetz T; Fätkenheuer G; Seifert H; Diehl V; Schrappe M
Randomized controlled monocentric comparison of once daily ceftriaxone with tobramycin and cefotaxime three times daily with tobramycin in neutropenic fever.
Annals of hematology 2001;80(2):103-8.
2001: zur Stadt U; Harms D O; Schlüter S; Schrappe M; Goebel U; Spaar H; Janka G; Kabisch H
MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(2):283-5.
2001: Seeger K; Viehmann S; Buchwald D; Harbott J; Schrappe M; Stary J; Henze G; Trka J
Treatment response and residual-disease monitoring in initial and relapsed TEL-AML1 positive childhood ALL.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(2):280-2.
2001: Scholz I; Popp S; Granzow M; Schoell B; Holtgreve-Grez H; Takeuchi S; Schrappe M; Harbott J; Teigler-Schlegel A; Zimmermann M; Fischer C; Koeffler H P; Bartram C R; Jauch A
Comparative genomic hybridization in childhood acute lymphoblastic leukemia: correlation with interphase cytogenetics and loss of heterozygosity analysis.
Cancer genetics and cytogenetics 2001;124(2):89-97.
2001: Grenzebach J; Schrappe M; Ludwig W D; Parwaresch R; Zimmermann M; Gadner H; Riehm H; Reiter A;
Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
Annals of hematology 2001;80 Suppl 3():B73-6.
2000: Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig W D; Henze G; Gadner H; Odenwald E; Riehm H
Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2205-22.
2000: Schrappe M; Camitta B; Pui C H; Eden T; Gaynon P; Gustafsson G; Janka-Schaub G E; Kamps W; Masera G; Sallan S; Tsuchida M; Vilmer E
Long-term results of large prospective trials in childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2193-4.
2000: Anderer G; Schrappe M; Brechlin A M; Lauten M; Muti P; Welte K; Stanulla M
Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
Pharmacogenetics 2000;10(8):715-26.
2000: Biondi A; Valsecchi M G; Seriu T; D'Aniello E; Willemse M J; Fasching K; Pannunzio A; Gadner H; Schrappe M; Kamps W A; Bartram C R; van Dongen J J; Panzer-Grümayer E R
Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(11):1939-43.
2000: Müller H J; Löning L; Horn A; Schwabe D; Gunkel M; Schrappe M; von Schütz V; Henze G; Casimiro da Palma J; Ritter J; Pinheiro J P; Winkelhorst M; Boos J
Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols.
British journal of haematology 2000;110(2):379-84.
2000: zur Stadt U; Harms D O; Schlüter S; Jorch N; Spaar H J; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
[Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase]
Klinische Pädiatrie 2000;212(4):169-73.
2000: Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig W D
Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
British journal of haematology 2000;110(1):154-60.
2000: Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig W D
Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Haematologica 2000;85(7):711-21.
2000: Karawajew L; Ruppert V; Wuchter C; Kösser A; Schrappe M; Dörken B; Ludwig W D
Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Blood 2000;96(1):297-306.
2000: Schrappe M; Reiter A; Ludwig W D; Harbott J; Zimmermann M; Hiddemann W; Niemeyer C; Henze G; Feldges A; Zintl F; Kornhuber B; Ritter J; Welte K; Gadner H; Riehm H
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Blood 2000;95(11):3310-22.
2000: Löning L; Zimmermann M; Reiter A; Kaatsch P; Henze G; Riehm H; Schrappe M
Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy.
Blood 2000;95(9):2770-5.
2000: Stanulla M; Stümm M; Dieckvoss B O; Seidemann K; Schemmel V; Müller Brechlin A; Schrappe M; Welte K; Reiter A
No evidence for a major role of heterozygous deletion 657del5 within the NBS1 gene in the pathogenesis of non-Hodgkin's lymphoma of childhood and adolescence.
British journal of haematology 2000;109(1):117-20.
2000: Stanulla M; Kasper B; Schrappe M; Viehmann S; Harbott J; Ludwig W D; Welte K
Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(2):337-8.
2000: Stanulla M; Schrappe M; Brechlin A M; Zimmermann M; Welte K
Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study.
Blood 2000;95(4):1222-8.
2000: Reiter A; Schrappe M; Ludwig W D; Tiemann M; Parwaresch R; Zimmermann M; Schirg E; Henze G; Schellong G; Gadner H; Riehm H
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report.
Blood 2000;95(2):416-21.
2000: Cornely O A; Salzberger B; Bethe U; Seifert H; Fätkenheuer G; Diehl V; Schrappe M
Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Antibiotics and chemotherapy 2000;50():37-46.
1999: Takeuchi S; Cho S K; Seriu T; Koike M; Bartram C R; Reiter A; Schrappe M; Takeuchi C; Taguchi H; Koeffler H P
Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia.
Oncogene 1999;18(51):7387-8.
1999: Reiter A; Schrappe M; Tiemann M; Ludwig W D; Yakisan E; Zimmermann M; Mann G; Chott A; Ebell W; Klingebiel T; Graf N; Kremens B; Müller-Weihrich S; Plüss H J; Zintl F; Henze G; Riehm H
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Blood 1999;94(10):3294-306.
1999: Dördelmann M; Reiter A; Borkhardt A; Ludwig W D; Götz N; Viehmann S; Gadner H; Riehm H; Schrappe M
Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
Blood 1999;94(4):1209-17.
1999: Graubner U B; Boos J; Creutzig U; Dörffel W; Lakomek M; Niemeyer C; Schrappe M; Spaar H J; Belohradsky B H
[Antiinfectious prophylaxis in pediatric oncology. Work group "Quality Assurance" of Society for Pediatric Oncology and Hematology (GPOH)]
Klinische Pädiatrie 1999;211(4):347-52.
1999: Müller A; Stellermann K; Hartmann P; Schrappe M; Fätkenheuer G; Salzberger B; Diehl V; Franzen C
A powerful DNA extraction method and PCR for detection of microsporidia in clinical stool specimens.
Clinical and diagnostic laboratory immunology 1999;6(2):243-6.
1999: Vieira Pinheiro J P; Ahlke E; Nowak-Göttl U; Hempel G; Müller H J; Lümkemann K; Schrappe M; Rath B; Fleischhack G; Mann G; Boos J
Pharmacokinetic dose adjustment of Erwinia asparaginase in protocol II of the paediatric ALL/NHL-BFM treatment protocols.
British journal of haematology 1999;104(2):313-20.
1998: van Dongen J J; Seriu T; Panzer-Grümayer E R; Biondi A; Pongers-Willemse M J; Corral L; Stolz F; Schrappe M; Masera G; Kamps W A; Gadner H; van Wering E R; Ludwig W D; Basso G; de Bruijn M A; Cazzaniga G; Hettinger K; van der Does-van den Berg A; Hop W C; Riehm H; Bartram C R
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
Lancet 1998;352(9142):1731-8.
1998: Schrappe M; Aricò M; Harbott J; Biondi A; Zimmermann M; Conter V; Reiter A; Valsecchi M G; Gadner H; Basso G; Bartram C R; Lampert F; Riehm H; Masera G
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
Blood 1998;92(8):2730-41.
1998: Ratei R; Sperling C; Karawajew L; Schott G; Schrappe M; Harbott J; Riehm H; Ludwig W D
Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia.
Annals of hematology 1998;77(3):107-14.
1998: Dördelmann M; Reiter A; Zimmermann M; Fengler R; Henze G; Riehm H; Schrappe M
Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1998;20(5):444-50.
1998: Seidemann K; Meyer U; Jansen P; Yakisan E; Rieske K; Führer M; Kremens B; Schrappe M; Reiter A
Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials.
Klinische Pädiatrie 1998;210(4):279-84.
1998: Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Klinische Pädiatrie 1998;210(4):192-9.
1998: Schrappe M; Reiter A; Riehm H
Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia.
Journal of neuro-oncology 1998;38(2-3):159-65.
1998: Schott G; Sperling C; Schrappe M; Ratei R; Martin M; Meyer U; Riehm H; Ludwig W D
Immunophenotypic and clinical features of T-cell receptor gammadelta+ T-lineage acute lymphoblastic leukaemia.
British journal of haematology 1998;101(4):753-5.
1998: Takeuchi S; Koike M; Seriu T; Bartram C R; Schrappe M; Reiter A; Park S; Taub H E; Kubonishi I; Miyoshi I; Koeffler H P
Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia.
Cancer research 1998;58(12):2618-23.
1998: Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(5):645-51.
1998: Müller A; Fätkenheuer G; Salzberger B; Schrappe M; Diehl V; Franzen C
[Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma]
Deutsche medizinische Wochenschrift (1946) 1998;123(13):381-5.
1998: Ritterbach J; Hiddemann W; Beck J D; Schrappe M; Janka-Schaub G; Ludwig W D; Harbott J; Lampert F
Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(3):427-33.
1998: Seeger K; Adams H P; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
Blood 1998;91(5):1716-22.
1998: Franzen C; Müller A; Hartmann P; Hegener P; Schrappe M; Diehl V; Fätkenheuer G; Salzberger B
Polymerase chain reaction for diagnosis and species differentiation of microsporidia.
Folia parasitologica 1998;45(2):140-8.
1997: Fätkenheuer G; Franzen C; Hartmann P; Wassermann K; Schrappe M; Dölken W; Diehl V; Salzberger B
[Cystic form of Pneumocystis carinii pneumonia]
Deutsche medizinische Wochenschrift (1946) 1997;122(47):1441-6.
1997: Conter V; Schrappe M; Aricó M; Reiter A; Rizzari C; Dördelmann M; Valsecchi M G; Zimmermann M; Ludwig W D; Basso G; Masera G; Riehm H
Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2786-91.
1997: Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi M G; Ludwig W D; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
Blood 1997;90(2):571-7.
1997: Mielcarek M; Sperling C; Schrappe M; Meyer U; Riehm H; Ludwig W D
Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome.
British journal of haematology 1997;96(2):301-7.
1996: Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2812-7.
1996: Schwenk A; Höffer-Belitz E; Jung B; Kremer G; Bürger B; Salzberger B; Diehl V; Schrappe M
Resting energy expenditure, weight loss, and altered body composition in HIV infection.
Nutrition (Burbank, Los Angeles County, Calif.) 1996;12(9):595-601.
1996: Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen J W; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram C R; Ludwig W D; Riehm H; Lampert F; Harbott J
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(6):957-63.
1996: Franzen C; Müller A; Diehl V; Schrappe M
[Microsporidia--biology and clinical relevance]
Medizinische Klinik (Munich, Germany : 1983) 1996;91(5):284-94.
1996: Schrappe M
[Clinical infectiology--I. Diagnosis, pathogen spectrum and resistance]
Medizinische Klinik (Munich, Germany : 1983) 1996;91 Suppl 1():166-75.
1996: Takeuchi S; Bartram C R; Miller C W; Reiter A; Seriu T; Zimmerann M; Schrappe M; Mori N; Slater J; Miyoshi I; Koeffler H P
Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1.
Blood 1996;87(8):3368-74.
1996: Welte K; Reiter A; Mempel K; Pfetsch M; Schwab G; Schrappe M; Riehm H
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
Blood 1996;87(8):3143-50.
1996: Franzen C; Kuppers R; Muller A; Salzberger B; Fatkenheuer G; Vetten B; Diehl V; Schrappe M
Genetic evidence for latent Septata intestinalis infection in human immunodeficiency virus-infected patients with intestinal microsporidiosis.
The Journal of infectious diseases 1996;173(4):1038-40.
1996: Salzberger B; Franzen C; Fätkenheuer G; Cornely O; Schwenk A; Rasokat H; Diehl V; Schrappe M
CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(4):365-9.
1996: Salzberger B; Stoehr A; Jablonowski H; Heise W; Ewald U; Peters K; Fätkenheuer G; Schrappe M
Foscarnet 5 versus 7 days a week treatment for severe gastrointestinal CMV disease in HIV-infected patients.
Infection 1996;24(2):121-4.
1995: Franzen C; Müller A; Schwenk A; Salzberger B; Fätkenheuer G; Mahrle G; Diehl V; Schrappe M
Intestinal microsporidiosis with Septata intestinalis in a patient with AIDS--response to albendazole.
The Journal of infection 1995;31(3):237-9.
1995: Franzen C; Müller A; Salzberger B; Fätkenheuer G; Eidt S; Mahrle G; Diehl V; Schrappe M
Tissue diagnosis of intestinal microsporidiosis using a fluorescent stain with Uvitex 2B.
Journal of clinical pathology 1995;48(11):1009-10.
1995: Fätkenheuer G; Diehl V; Schrappe M
[Clinical aspects and therapy of ubiquitous mycobacterioses]
Der Internist 1995;36(10):987-94.
1995: Franzen C; Müller A; Hegener P; Salzberger B; Hartmann P; Fätkenheuer G; Diehl V; Schrappe M
Detection of microsporidia (Enterocytozoon bieneusi) in intestinal biopsy specimens from human immunodeficiency virus-infected patients by PCR.
Journal of clinical microbiology 1995;33(9):2294-6.
1995: Franzen C; Salzberger B; Fätkenheuer G; Ziegenhagen D; Cornely O; Diehl V; Schrappe M
Stimulated duodenal/bile juice aspiration for diagnosis of enteric pathogens in HIV-infected patients.
Journal of clinical gastroenterology 1995;21(1):33-7.
1995: Jablonowski H; Arasteh K; Staszewski S; Ruf B; Stellbrink H J; Schrappe M; Stoehr A; Haase W; Schomaker U; von Eisenhart Rothe B
A dose comparison study of didanosine in patients with very advanced HIV infection who are intolerant to or clinically deteriorate on zidovudine. German ddI Trial Group.
AIDS (London, England) 1995;9(5):463-9.
1995: Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora K W; Ludwig W D; Gadner H; Riehm H
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):359-72.
1995: Schrappe M; Salzberger B
[Fever in immunosuppressed patients]
Der Internist 1995;36(2):162-9.
1994: Salzberger B; Schrappe M; Diehl V
[Antiretroviral therapy in adult HIV-infected patients]
Der Internist 1994;35(12):1095-104.
1994: Schrappe M
[Clinical infectiology update. I: Diagnosis, pathogen spectrum and resistance]
Medizinische Klinik (Munich, Germany : 1983) 1994;89(12):652-61.
1994: Reiter A; Schrappe M; Ludwig W D; Hiddemann W; Sauter S; Henze G; Zimmermann M; Lampert F; Havers W; Niethammer D
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.
Blood 1994;84(9):3122-33.
1994: Bürger B; Schwenk A; Jünger H; Ollenschläger G; Wessel D; Diehl V; Schrappe M
Oral supplements in HIV-infected patients with chronic wasting. A prospective trial.
Medizinische Klinik (Munich, Germany : 1983) 1994;89(11):579-81, 633.
1994: Franzen C; Fätkenheuer G; Salzberger B; Müller A; Mahrle G; Diehl V; Schrappe M
Intestinal microsporidiosis in patients with acquired immunodeficiency syndrome--report of three more German cases.
Infection 1994;22(6):417-9.
1994: Schmitz S H; Scheding S; Voliotis D; Rasokat H; Diehl V; Schrappe M
Side effects of AZT prophylaxis after occupational exposure to HIV-infected blood.
Annals of hematology 1994;69(3):135-8.
1994: Reiter A; Schrappe M; Yakisan E; Sauter S; Ebell W; Zimmermann M; Hartmann W; Kremens B; Kuhn N; Claviez A
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL]
Klinische Pädiatrie 1994;206(4):242-52.
1994: Reiter A; Schrappe M; Yakisan E; Sauter S; Henzler D; Zimmermann M; Graf N; Fengler R; Kühl J; Fleischhack G
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 2: An intermediate term analysis of the non-B-NHL therapy group. BFM Study group]
Klinische Pädiatrie 1994;206(4):234-41.
1994: Reiter A; Tiemann M; Ludwig W D; Wacker H H; Yakisan E; Schrappe M; Henzler D; Sykora K W; Brandt A; Odenwald E
[NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group]
Klinische Pädiatrie 1994;206(4):222-33.
1994: Reiter A; Schrappe M; Tiemann M; Parwaresch R; Zimmermann M; Yakisan E; Dopfer R; Bucsky P; Mann G; Gadner H
Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(5):899-908.
1994: Salzberger B; Stoehr A; Heise W; Fätkenheuer G; Schwenk A; Franzen C; Cornely O; Schrappe M
Foscarnet and ganciclovir combination therapy for CMV disease in HIV-infected patients.
Infection 1994;22(3):197-200.
1993: Schwenk A; Büger B; Wessel D; Stützer H; Ziegenhagen D; Diehl V; Schrappe M
Clinical risk factors for malnutrition in HIV-1-infected patients.
AIDS (London, England) 1993;7(9):1213-9.
1993: Franzen C; Fätkenheuer G; Salzberger B; Ziegenhagen D; Seitz H M; Diehl V; Schrappe M
[Isospora belli infection in an AIDS patient]
Medizinische Klinik (Munich, Germany : 1983) 1993;88(5):330-2.
1993: Bürger B; Ollenschläger G; Schrappe M; Stute A; Fischer M; Wessel D; Schwenk A; Diehl V
Nutrition behavior of malnourished HIV-infected patients and intensified oral nutritional intervention.
Nutrition (Burbank, Los Angeles County, Calif.) 1993;9(1):43-4.
1992: Reiter A; Schrappe M; Ludwig W D; Lampert F; Harbott J; Henze G; Niemeyer C M; Gadner H; Müller-Weihrich S; Ritter J
Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group.
Blood 1992;80(10):2471-8.
1992: Schrappe M; Wassermann K; Ziegenhagen D; Salzberger B; Fätkenheuer G; Schwenk A; Hiersche A; Diehl V
[Pneumocystis carinii in oncologic diseases]
Medizinische Klinik (Munich, Germany : 1983) 1992;87 Suppl 1():65-70.
1992: Franzen C; Salzberger B; Fätkenheuer G; Eidt S; Schrappe M
[Mucosa-associated immune system in HIV-1 infection. T-cell subpopulations compared in different segments of the gastrointestinal tract]
Medizinische Klinik (Munich, Germany : 1983) 1992;87(10):510-2, 549.
1991: Schrappe M; Pohl C; Tesch H; Diehl V
[HIV-associated non-hodgkin lymphoma. Prognosis and therapeutic options]
Medizinische Klinik (Munich, Germany : 1983) 1991;86(12):646-54, 660.
1987: Schrappe M; Beck J; Brandeis W E; Feickert H J; Gadner H; Graf N; Havers W; Henze G; Jobke A; Kornhuber B
[Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81]
Klinische Pädiatrie 1987;199(3):133-50.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Martin Schrappe

Research Profile (preview)

Disorders

Living Beings

Procedures

Concepts & Ideas

Chemicals & Drugs

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Martin Schrappe (preview)

All Publications